Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal antibodies as alternative approaches

Recent Results Cancer Res. 2007;172:59-76. doi: 10.1007/978-3-540-31209-3_5.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Mice
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology*
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use*
  • Receptor, IGF Type 1 / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Protein Kinase Inhibitors
  • Receptor, IGF Type 1